HKU on Coronavirus (Mar 7-13)


HKU in the news (May 7-May 13)

May 13 HKU microbiologist Professor Yuen kwok-yung concludes Novel coronavirus most likely came from Asian bat (Professor Yuen Kwok-yun) (link)

May 13 HKU microbiologist Professor Yuen kwok-yung worries new Covid-19 infections in Hong Kong may delay plans to resume classes on May 27 (Professor Yuen Kwok-yun) (link)

May 13 HKU study shows COVID-19 may be capable of infecting human intestinal tract (link)

May 12 HKU Faculty of Dentistry co-develops new faceshield with a local company which can cover forehead and face completely so dentists do not have to worry about transmission by droplets (Professor Gary Cheung) (link)

May 12 HKUMed School of Public Health Director Professor Keiji Fukuda thinks reopening of border should start selectively with students and businesspeople (Professor Keiji Fukuda) (link)

May 11 HKU organises the “Virtual Forum on HKU’s Big Ideas on Combatting the COVID-19 Pandemic” forum aimed at generating “big ideas” to address global challenges via innovative research in an interdisciplinary setting (link)

May 10 HKU launches the “HKU Sync with U ” initiative to bring positive energy through music to DSE candidates, front-line healthcare workers, cleaners and all Hong Kongers (link)

May 9 HKU mental health expert studies Covid-19 pandemic’s impact on emotion through big data from Weibo and HKGolden posts using linguistic analysis (Professor Paul Yip Siu-fai) (link)

May 9 HKU study published in the Lancet finds therapy combining three antiviral drugs is safer and more effective than single-drug treatments in reducing the viral load in less severe Covid-19 patients (Professor Yuen Kwok-yun) (link)

May 8 HKU PhD in Chemistry “K Kwong” carries out tests on CU masks by the government and finds the filtering efficiency fell by 20% after washing the mask once (Dr. Kenneth Kwong) (link)

May 8 HKU study finds eyes are 'important route' for coronavirus, up to 100 times more infectious than Sars (Dr. Michael Chan) (link)

May 7 HKUMed is studying to treat patients with severe symptoms with blood plasma donated by patients who recovered from COVID-19 and with enough neutralizing antibody level (Professor Ivan Hung) (link)